Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Modulo Bio is focused on reprogramming the brain's immune system, specifically targeting microglia to develop treatments for neurological conditions. Their innovative platform combines advanced data…

Modulo Bio is focused on reprogramming the brain's immune system, specifically targeting microglia to develop treatments for neurological conditions. Their innovative platform combines advanced data…
Focus: Reprogramming the brain's immune system (microglia) to discover neuroprotective therapies
Headquarters: San Diego, CA
Founded: 2021
Employees (approx.): 12
Known investors: Initialized Capital; Alzheimer's Drug Discovery Foundation; Cantos; Hawktail Management; Refactor; Builders VC; Bioverge; Spacecadet Ventures; The ALS Association
Reported total funding: USD 23,055,780
Neurological and central nervous system disorders driven by neuroimmune dysfunction
2021
Biotechnology
8,000,000 USD
Seed round announced June 1, 2023
4,800,000 USD
Reported strategic investment
500,000 USD
Awarded grant
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
400+
New This Week